MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.

Background: The albumin bilirubin (ALBI) score and model of end stage liver disease (MELD) are prognostic in patients with hepatocellular carcinoma (HCC). Aim was to compare MELD-sarcopenia to MELD and ALBI scores in patients with HCC awaiting liver transplantation.

Methods: patients with HCC (n=262) were included and followed up for 12 months.

Predictors of early recipient mortality after living donor liver transplantation in a tertiary care center in Egypt.

Background: Living donor liver transplantation (LDLT) has evolved into a widely accepted therapeutic option. Many different risk factors may affect early mortality after LDLT.

Objectives: Analyze risk factors that can affect early (<6 months) mortality of patients after LDLT in a single center.